They’ve cured countless childhood diseases and dragged us out of the Covid pandemic, and now, vaccines could be set to treat and prevent Alzheimer’s disease.
After decades of failed trials, ineffective drugs and billions of dollars spent, a new frontier of shots offer a glimmer of hope for current and future sufferers of the cruel condition that affects 5.8million Americans.
While there have been recent breakthroughs with the approval of IV treatment Leqembi and the soon-to-be-approved drug donanemab, these require hours-long infusions multiple times a month and can cost up to $26,000 per year. And effects are marginal at best – giving patients a few extra months of health.
Read more here
Alexa Lardieri 